机译:将HMG HMG -COA还原酶抑制剂施用的alt ALT水平的变化在临床实践中的预处理水平的预处理水平的对象
College of PharmacySookmyung Women's UniversitySeoul Korea;
Department of Industrial and Management EngineeringPohang University of Science and TechnologySeoul;
Department of Medical InformaticsThe Catholic University of KoreaSeoul Korea;
Department of Medical InformaticsThe Catholic University of KoreaSeoul Korea;
Department of Medical InformaticsThe Catholic University of KoreaSeoul Korea;
Division of Endocrinology and MetabolismThe Catholic University of KoreaSeoul Korea;
Division of Endocrinology and MetabolismThe Catholic University of KoreaSeoul Korea;
Clinical Research Coordinating CenterThe Catholic University of KoreaSeoul Korea;
Department of Preventive MedicineThe Catholic University of KoreaSeoul Korea;
Department of Medical InformaticsThe Catholic University of KoreaSeoul Korea;
Department of Medical InformaticsThe Catholic University of KoreaSeoul Korea;
Department of Medical InformaticsThe Catholic University of KoreaSeoul Korea;
dyslipidemia; hepatotoxicity; hypercholesterolemia; statin;
机译:将HMG HMG -COA还原酶抑制剂施用的alt ALT水平的变化在临床实践中的预处理水平的预处理水平的对象
机译:HMG-CoA还原酶抑制剂对氯沙坦及其主要代谢产物EXP-3174在大鼠体内的药代动力学的影响:CYP3A4和HMG-CoA还原酶抑制剂对P-gp抑制的可能作用。
机译:血清胆固醇水平,HMG-CoA还原酶抑制剂和脑出血的风险。意大利脑出血的多中心研究(意大利MUCH)
机译:3,5-二羟基庚烯酸酯作为3-羟基-3-甲基-戊二酰辅酶A还原酶(HMGR)抑制剂的对接研究
机译:脑部疟疾的新疗法:HMG-CoA还原酶抑制剂的作用和抗凋亡策略在实验性脑部疟疾中的研究。
机译:临床实验室报告的血清ALT水平的正常上限取决于当地参考人群
机译:五种不同HMG-COA还原酶抑制剂在培养的人细胞中,HMG CoA还原酶和LDL受体的MRNA相对诱导
机译:HmG-COa还原酶抑制剂治疗对高脂血症LDL胆固醇血液水平的影响:纵向回顾性分析使用国防部综合数据库